Princeton Alpha Management’s GSK GSK Stock Holding History

Princeton Alpha Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-6,166	Closed	-$325K	–	155
2017 Q1	$325K	Sell	6,166 -1,048	-15%	-$53.2K	0.11%	326
2016 Q4	$347K	Sell	7,214 -3,024	-30%	-$149K	0.07%	413
2016 Q3	$552K	Buy	10,238 +3,004	+42%	+$165K	0.1%	305
2016 Q2	$392K	Buy	+7,234	New	+$381K	0.07%	426
2014 Q3	–	Sell	-10,841	Closed	-$725K	–	723
2014 Q2	$725K	Buy	+10,841	New	+$734K	0.15%	206
2014 Q1	–	Sell	-10,368	Closed	-$692K	–	662
2013 Q4	$692K	Buy	+10,368	New	+$672K	0.51%	22

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Princeton Alpha Management's GSK Position: Q2 2017 in Review

Princeton Alpha Management sold out of GSK (GSK) in Q2 2017, closing a stake of 6,166 shares — an estimated $325K sold.

Princeton Alpha Management first reported a position in GSK in Q4 2013 and held it in 6 quarters. The position peaked at $725K in Q2 2014. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

Princeton Alpha Management reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
Princeton Alpha Management sold 6,166 GSK shares in Q2 2017, an estimated $325K.
Princeton Alpha Management first reported a position in GSK in Q4 2013 and held it in 6 quarters.
Princeton Alpha Management's GSK position peaked at $725K in Q2 2014.
779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Princeton Alpha Management's 13F filing for Q2 2017.